Clindamycin has activity against Toxoplasma gondii. In patients with disease limited to the eye, local treatment may be an option. Case series and one randomised controlled trial of patients with chorioretinitis have shown some benefit with this treatment.[63]Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina. 2007 Sep;27(7):952-7.
http://www.ncbi.nlm.nih.gov/pubmed/17891023?tool=bestpractice.com
[65]Baharivand N, Mahdavifard A, Fouladi RF, et al. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial. Int Ophthalmol. 2013 Feb;33(1):39-46.
http://www.ncbi.nlm.nih.gov/pubmed/23053769?tool=bestpractice.com